Ou G, Liu Y, Tang Y, You X, Zeng Y, Xiao J, Chen L, Yu M, Wang M, Zhu C
Institution of Pathogenic Biology, Medical College, University of South China, Hunan Provincial Key, Laboratory for Special Pathogens Prevention and Control, Hengyang City, Hunan Province, P.R. China.
Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, P.R. China.
Hippokratia. 2015 Jan-Mar;19(1):57-62.
This study aims to investigate the inducing effect of subminimum inhibitory concentrations of macrolide antibiotics on Mycoplasma pneumoniae (M. pneumoniae) resistance to drugs.
One M. pneumoniae reference strain M129 (ATCC 29342) and 104 clinical isolates were incubated at 37C for 6-8 days. Genomic DNA of M. pneumoniae was extracted using TIANamp Bacteria DNA kit and amplified by polymerase chain reaction (PCR).
Ten sensitive isolates obtained from 104 M. pneumoniae clinical isolates were induced by subminimum inhibitory concentrations of macrolide antibiotics. Among them, three were found to possess mutations in L4 and L22 ribosomal proteins. Two cases carried simultaneously the C162A and A430G mutations of L4 and the T279C mutation of L22. In addition, one case had only the A209T mutation of L4.
Repeated in vitro exposure to subminimum inhibitory concentrations of macrolide antibiotics could induce selective mutations in ribosomal genes of M. pneumoniae clinical isolates that cause resistance to macrolide antibiotics. Hippokratia 2015, 19 (1): 57-62.
本研究旨在探讨低于最低抑菌浓度的大环内酯类抗生素对肺炎支原体(M. pneumoniae)耐药性的诱导作用。
将一株肺炎支原体参考菌株M129(ATCC 29342)和104株临床分离株在37℃孵育6 - 8天。采用天根细菌基因组DNA提取试剂盒提取肺炎支原体基因组DNA,并通过聚合酶链反应(PCR)进行扩增。
从104株肺炎支原体临床分离株中获得的10株敏感菌株被低于最低抑菌浓度的大环内酯类抗生素诱导。其中,3株在L4和L22核糖体蛋白中发现有突变。2例同时携带L4的C162A和A430G突变以及L22的T279C突变。此外,1例仅具有L4的A209T突变。
体外反复暴露于低于最低抑菌浓度的大环内酯类抗生素可诱导肺炎支原体临床分离株核糖体基因发生选择性突变,从而导致对大环内酯类抗生素产生耐药性。《希波克拉底》2015年,第19卷(第1期):57 - 62页。